Mark Kowieski - 07 Aug 2024 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Role
Chief Financial Officer
Signature
/s/ Mark Kowieski
Issuer symbol
EVOK
Transactions as of
07 Aug 2024
Net transactions value
$0
Form type
4
Filing time
08 Aug 2024, 17:11:22 UTC
Previous filing
30 May 2024
Next filing
29 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVOK Stock Option (Right to Buy) Award $0 +17,291 $0.000000 17,291 07 Aug 2024 Common Stock 17,291 $5.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares subject to the options shall vest on each monthly anniversary of August 7, 2024 (the "Vesting Commencment Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.